HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype

Minor histocompatibility (H) antigens are targets of graft‐vs‐host disease and graft‐vs‐tumor responses after human leukocyte antigen matched allogeneic hematopoietic stem cell transplantation. Recently, we reported a strategy for genetic mapping of linkage disequilibrium blocks that encoded novel m...

Full description

Saved in:
Bibliographic Details
Published inTissue antigens Vol. 80; no. 2; pp. 119 - 125
Main Authors Yamamura, T., Hikita, J., Bleakley, M., Hirosawa, T., Sato-Otsubo, A., Torikai, H., Hamajima, T., Nannya, Y., Demachi-Okamura, A., Maruya, E., Saji, H., Yamamoto, Y., Takahashi, T., Emi, N., Morishima, Y., Kodera, Y., Kuzushima, K., Riddell, S. R., Ogawa, S., Akatsuka, Y.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Minor histocompatibility (H) antigens are targets of graft‐vs‐host disease and graft‐vs‐tumor responses after human leukocyte antigen matched allogeneic hematopoietic stem cell transplantation. Recently, we reported a strategy for genetic mapping of linkage disequilibrium blocks that encoded novel minor H antigens using the large dataset from the International HapMap Project combined with conventional immunologic assays to assess recognition of HapMap B‐lymphoid cell line by minor H antigen‐specific T cells. In this study, we have constructed and provide an online interactive program and demonstrate its utility for searching for single‐nucleotide polymorphisms (SNPs) responsible for minor H antigen generation. The website is available as ‘HapMap SNP Scanner’, and can incorporate T‐cell recognition and other data with genotyping datasets from CEU, JPT, CHB, and YRI to provide a list of candidate SNPs that correlate with observed phenotypes. This method should substantially facilitate discovery of novel SNPs responsible for minor H antigens and be applicable for assaying of other specific cell phenotypes (e.g. drug sensitivity) to identify individuals who may benefit from SNP‐based customized therapies.
Bibliography:Figure S1. Distributions of optical density values of individual CTL-K9.3 clone against HapMap B-lymphoid cell lines (B-LCLs) assayed by enzyme-linked immunosorbent assay (ELISA). HapMap CEU B-LCLs were transduced with HLA-B*07:02 cDNA and assayed for their minor H antigen status by interferon-γ ELISA at a predetermined Responder : Stimulator ratio. Assays were performed at least in duplicate. Dotted lines indicate threshold for antigen-negative and antigen-positive subjects.Table S1. Human leukocyte antigen genotypes of CEU Individuals.Table S2. Human leukocyte antigen genotypes of CHB Individuals.Table S3. Human leukocyte antigen genotypes of JPT Individuals.
istex:2F4FE4319317EB711101EC34870727B3DF328E66
ark:/67375/WNG-855KCWHZ-K
ArticleID:TAN1883
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0001-2815
1399-0039
DOI:10.1111/j.1399-0039.2012.01883.x